Results 101 to 110 of about 545,250 (204)

A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes

Biology Open, 2023
Laura Schubert, Anh T. Le, Trista K. Hinz, Andre C. Navarro, Sarah K. Nelson-Taylor, Raphael A. Nemenoff, Lynn E. Heasley, Robert C. Doebele   +7 more
doaj   +1 more source

Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis. [PDF]

Front Immunol
He Y, Hung SW, Liang B, Zhang R, Gao Y, Chu CY, Zhang T, Xu H, Chung JPW, Wang CC.   +9 more
europepmc   +1 more source

Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation [PDF]

, 2017
Galemmo, Robert A, Jr, Han, Zhenfu, Janetka, James W, Klampfer, Lidija, Owusu, Benjamin Y, Thomas, Shantasia, Venukadasula, Phanindra   +6 more
core   +2 more sources

Antagonists of the N-cadherin/Fibroblast growth factor receptor tyrosine kinase complex. [PDF]

Tissue Barriers
Blaschuk OW.
europepmc   +1 more source

N-myristoyltransferase 1-mediated Src Myristoylation Promotes Non-receptor Tyrosine Kinase Pathways in Oral Squamous Cell Carcinoma. [PDF]

In Vivo
Komiyama T, Sugiyama G, Kamohara H, Fujinaga T, Kumamaru W, Moriyama M.   +5 more
europepmc   +1 more source

The Role of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Cancer Stem Cell Signaling. [PDF]

Int J Mol Sci
Jung MS, Choi WY, Zhang W, Barrera FN, Perkins RS.   +4 more
europepmc   +1 more source

Non-receptor tyrosine kinase c-Abl downstream of C-type lectin receptors regulates innate antifungal immunity through c-Cbl/MAPK pathway. [PDF]

Infect Immun
Ma S-J, Xie K-F, Duan J-L, Wang X-L, Yang Y-H, Wang Y.   +5 more
europepmc   +1 more source

The receptor tyrosine kinase ErbB2/HER2 governs CDK4 inhibitor sensitivity, timing, and irreversibility of the G1/S transition. [PDF]

J Biol Chem
Nagasato-Ichikawa A, Murakami K, Aoki K, Okada M.   +3 more
europepmc   +1 more source

[Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhan S, Chen P, Lv T, Song Y.
europepmc   +1 more source

Discoidin domain receptor tyrosine kinase 2: A new perspective on microenvironment remodeling and targeted therapy of solid tumors (Review). [PDF]

Oncol Lett
Lu T, Guo H, Gong H, Ma Y, Tian Y, Zhang D.   +5 more
europepmc   +1 more source